Artificial oxygen carriers / blood doping methods
Muscle & Strength · Oxygen delivery manipulation
Tier C
High-risk evidence profile
Bottom line
Read Off Label grades Artificial oxygen carriers / blood doping methods as C (4.7/10) based on moderate evidence, high benefit magnitude, and a high-risk safety profile.
Its high-risk evidence profile reflects a Safety score of 2/10; reported benefits and harms can differ by indication, dose, route, duration, and population.
WADA coverage: perfluorochemicals, efaproxiral/RSR13, voxelotor, modified haemoglobin products, haemoglobin-based blood substitutes and microencapsulated haemoglobin products.
Studied, labeled, or reported-use context: Not a consumer dosing intervention — Medical/research/procedure context only; WADA M1 prohibited method; not individualized guidance.
What the evidence says
WADA coverage: perfluorochemicals, efaproxiral/RSR13, voxelotor, modified haemoglobin products, haemoglobin-based blood substitutes and microencapsulated haemoglobin products. Transfusion-style blood manipulation is outside routine health optimization and carries major medical and anti-doping risk.
Mechanism
Artificial oxygen carriers and blood manipulation aim to increase oxygen uptake, transport or delivery independent of training adaptations.
Studied, labeled, or reported dose & route
Not a consumer dosing intervention
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Artificial oxygen carriers / blood doping methods's effects?
- Read Off Label rates the evidence for Artificial oxygen carriers / blood doping methods as Moderate and the benefit magnitude as high, producing an overall grade of C (4.7/10). WADA coverage: perfluorochemicals, efaproxiral/RSR13, voxelotor, modified haemoglobin products, haemoglobin-based blood substitutes and microencapsulated haemoglobin products.
- What safety findings are reported for Artificial oxygen carriers / blood doping methods?
- Artificial oxygen carriers / blood doping methods has a high risk profile in the database. High (thrombosis, hypertension, hemolysis, infection/procedural risk, oxygen-carrier toxicity) Legal status: Medical/research/procedure context only; WADA M1 prohibited method.
- What does the low Safety score for Artificial oxygen carriers / blood doping methods represent?
- The Safety score is 2/10. It records the substantial harms described for one or more use contexts; the Benefit score, indication, dose, route, duration, population, and legal status remain separate parts of the evidence profile.
- What doses or routes are reported for Artificial oxygen carriers / blood doping methods?
- Not a consumer dosing intervention This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Artificial oxygen carriers / blood doping methods work?
- Artificial oxygen carriers and blood manipulation aim to increase oxygen uptake, transport or delivery independent of training adaptations.
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.